FrançaisAre analysts right about Acadia Healthcare (ACHC)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Acadia Healthcare, we replayed every analyst price target of the past 12 months and measured the real outcome: 30% were profitable, average return -1% (95 calls). At 3 months: +1% average return (42% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| RBC Capital | 11 | 9% | -34% |
| Raymond James | 9 | 44% | +43% |
| Barclays | 8 | 0% | -51% |
| B of A Securities | 7 | 57% | +6% |
| UBS | 7 | 29% | -0% |
Frequently asked questions
Is Acadia Healthcare a buy right now?
The analyst consensus on Acadia Healthcare (ACHC) is "Buy" (27 bullish, 1 bearish calls over 12 months). This is not advice: historically, 30% of their targets on this stock turned out profitable over 1 year.
What is Acadia Healthcare's price target?
The median 12-month price target is $34.00 (+12% vs $30.22), ranging from $30.00 to $40.00 (8 analysts).
Are analysts accurate on Acadia Healthcare?
Over 1 year, 30% of analyst targets on Acadia Healthcare were profitable, for an average return of -1% (across 95 timestamped calls). This is JPI Invest's accuracy metric.
What is the Acadia Healthcare stock forecast?
Analysts target a median of $34.00 within 12 months, i.e. +12% vs the current price. The most bullish targets $40.00, the most cautious $30.00.
What is the Acadia Healthcare stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $34.00, +12%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (30%), and the stock's past trajectory.
Is Acadia Healthcare overvalued?
Detailed valuation data for Acadia Healthcare is available in the interactive analysis.
📊 See the full interactive analysis of Acadia Healthcare →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.